Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration
- PMID: 27654922
- DOI: 10.1007/s10534-016-9971-z
Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration
Abstract
Zinc importer proteins (ZIPs) have been proven as important molecular regulators in different cancers. As a member of the solute carrier family, ZIP9/SLC39A9 is overexpressed in prostate and breast cancer and affects B-cell receptor signaling. Here, we present data indicating that changes in intracellular zinc levels in glioblastoma cells can cause enhanced cell survival and cell migration, both hallmarks of the disease process. In particular, treatment of human glioblastoma cells with sublethal doses of cell-permeable heavy metal (Zn2+ > Fe2+ > Mn2+) chelator (N,N,N',N'-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN)) induced ZIP9 expression. Either TPEN treatment or expression of ZIP9 cDNA causes enhanced migration behavior of glioblastoma cells. Compared to untreated glioblastoma cells TPEN treatment or expression of ZIP9 results in activation of the tumor suppressor p53 by phosphorylation at serine residue 46 (Ser46) and in inactivation of the migration relevant glycogen synthase kinase 3 beta (GSK-3β) by phosphorylation at serine residue 9 (Ser9). Whilst p53 activation affects cell survival in response to TPEN, GSK-3β inactivation directly affects glioblastoma cell migration. Therefore, ZIP9 expression could regulate the migratory behavior of glioblastoma cells, so that ZIP9 may be of biological, but not of clinical relevance for glioblastomas, since in GBM tumor tissues, ZIP9 expression is not significantly increased compared to normal brain.
Keywords: Cell migration; GSK-3beta; Glioblastoma; TPEN; ZIP9; Zinc metabolism; p53.
Similar articles
-
Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis.Endocrinology. 2014 Nov;155(11):4250-65. doi: 10.1210/en.2014-1201. Epub 2014 Jul 11. Endocrinology. 2014. PMID: 25014355 Free PMC article.
-
Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.Oncotarget. 2017 Apr 4;8(14):22811-22824. doi: 10.18632/oncotarget.15206. Oncotarget. 2017. PMID: 28423558 Free PMC article. Clinical Trial.
-
Genome-Wide Analysis Reveals Zinc Transporter ZIP9 Regulated by DNA Methylation Promotes Radiation-Induced Skin Fibrosis via the TGF-β Signaling Pathway.J Invest Dermatol. 2020 Jan;140(1):94-102.e7. doi: 10.1016/j.jid.2019.04.027. Epub 2019 Jun 27. J Invest Dermatol. 2020. PMID: 31254515
-
A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.Biochem Genet. 2016 Oct;54(5):573-618. doi: 10.1007/s10528-016-9754-9. Epub 2016 Jul 4. Biochem Genet. 2016. PMID: 27377891 Review.
-
Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme.J Clin Neurosci. 2013 Sep;20(9):1185-92. doi: 10.1016/j.jocn.2013.02.003. Epub 2013 Jun 12. J Clin Neurosci. 2013. PMID: 23768967 Review.
Cited by
-
Slc39a5-mediated zinc homeostasis plays an essential role in venous angiogenesis in zebrafish.Open Biol. 2020 Oct;10(10):200281. doi: 10.1098/rsob.200281. Epub 2020 Oct 21. Open Biol. 2020. PMID: 33081634 Free PMC article.
-
CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation.Glycobiology. 2023 Oct 29;33(9):700-714. doi: 10.1093/glycob/cwad003. Glycobiology. 2023. PMID: 36648436 Free PMC article.
-
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling.Oncogene. 2020 Jan;39(3):574-586. doi: 10.1038/s41388-019-0964-6. Epub 2019 Sep 10. Oncogene. 2020. PMID: 31506605
-
Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.Stem Cells Transl Med. 2019 Sep;8(9):911-924. doi: 10.1002/sctm.18-0256. Epub 2019 Mar 28. Stem Cells Transl Med. 2019. PMID: 30924311 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous